1 / 43

Cytotoxic T Lymphocytes (CTLs) and NK Cells

Cytotoxic T Lymphocytes (CTLs) and NK Cells. After activation, naïve T cells differentiate into effector and memory T cells. After activation, T cells remain in lymph nodes for 5-6 days. Effector T cells. CTLs do not require costimulation to kill infected targets.

willem
Télécharger la présentation

Cytotoxic T Lymphocytes (CTLs) and NK Cells

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cytotoxic T Lymphocytes (CTLs) and NK Cells

  2. After activation, naïve T cells differentiate into effector and memory T cells

  3. After activation, T cells remain in lymph nodes for 5-6 days

  4. Effector T cells

  5. CTLs do not require costimulation to kill infected targets

  6. Chromium Release AssayExperiments demonstrating CTL killing of target cells are usually done with a chromium (51Cr) release assay, which measures target cell lysis in 4-8 hours. Infect mouse with virus to generate CTLs specific for virus infected targets. Wait until mouse has generated immune response. Use Spleen as source of CTLs. Incubate with syngeneic targets infected with virus that are radioactively labeled with 51Cr that will be released when cell is lysed. Chromium attaches to proteins in the cytoplasm of target cells

  7. Chromium Release CTL Assay • Target cells mixed with • effector cells at various ratios. • Measure release of 51Cr into media. • Express as percentage lysis • relative to non-specific effector cell.

  8. How do CTL kill target cells? Perforin/ Granzyme B Pathway Directional release of granules (in red).

  9. CTL Killing Perforin • Contained in CTL granules • Pore forming protein. • Pokes holes in target cell membrane. • Homologous to C9.

  10. CTL Killing Perforin forms polymers that poke holes in membranes to allow enzymes inside cell.

  11. CTL Killing Granzymes • A family of proteases which are involved in induction of apoptosis in target cells after entry through perforin pores. • Granzyme = granule enzyme • Granzyme B is most active granzyme.

  12. CTL KillingPerforin/Granzyme pathway Antigen specific killing of infected target cells allows for reduced bystander killing of uninfected cells.

  13. CTL KillingSelective (antigen specific) killing happens in minutes. CTLs can be serial killers (repeatedly killing).

  14. Why don't CTLS kill themselves? Cathepsin B-- a protease which cleaves perforin!!! Anti-cathepsinB control

  15. Perforin deficient mice can still kill virally-infected target cells. How? Virus Virus Wildtype Perforin KO Harvest splenocytes Harvest splenocytes 51Cr labeled targets Specific killing of virally infected targets Specific killing of virally infected targets

  16. Fas/Fas Ligand Pathway CTLs express Fas ligand interact with Fas expressed on the target cell surface.

  17. Fas Induced ApoptosisCascade of Caspases • Proteases that cut at C-terminal side of an aspartate. • Pro-enzyme form becomes active through cleavage into subunits. • Proteolytic cascade must be activated for eventual DNA fragmentation.

  18. Fas Induced Apoptosis

  19. Bcl-2 Proteins Control ApoptosisPro-apoptosis and anti-apoptosis proteins • Bcl-2 proteins can inhibit or activate apoptosis. • Proteolytic cascade must be activated and not inhibited by anti-apototic bcl-2 proteins. (Target cell has to want to commit suicide).

  20. CTL Pathways of Cytotoxicity

  21. Summary Naïve CD8 T cells are activated in secondary lymphoid organs and differentiate into CTL effector cells. CTLs can kill targets independently of costimulation. Once a CTL encounters a target cell it releases cytotoxic granules containing perforin and granzymes. Perforin forms pores in the membrane of the target cell allowing granzymes to enter the cell. Granzymes induce apoptosis in the target cell by cleaving caspases. CTL also express FasL and can kill targets via Fas expressed on target cells.

  22. But CTLS are not enough…..Viruses are tricky! • Class I MHC inhibition by viruses • Virus Protein Effect on class I • Adenovirus E3-k19 Retain in ER • HSV-1,2 ICP47 Blocks TAP • EBV EBNA1 Block peptides • CMV US2 ER to cytosol • CMV US3 Retain in ER • CMV US6 Blocks TAP

  23. C M V i n f e c t e d N o n - i n f e c t e d a n t i - c l a s s I c I g a n t i - c l a s s I NK Cells Detect "Missing Self"Protection Against Viruses Immune evasion mechanism of viruses to decrease Class I MHC. NK cells preferentially kill cells that have lost expression of MHC class I. CMV infection down-regulated MHC class I on human fibroblasts

  24. NK Cells Detect "Missing Self"Immune surveillance for Tumors Tumor cells often have decreased expression of Class I MHC to escape T cell recognition. NK cells kill tumor cells.

  25. NK cells • Distinct lineage of lymphocytes. • Do not rearrange a,b,g or d TCR. • CD3-,CD56+ in humans. • CD3-,NKR-P1+ (NK1.1) in rodents • Effector functions include cell-mediated cytotoxicity & cytokine secretion.

  26. NK and T cell Development T C R R e a r r a n g e m e n t P r e - T P r e - T S t e m C e l l M a t u r e T T / N K P r o g e n i t o r + + + C D 3 C D 3 C D 3 T h y m u s + + + + + C D 4 o r C D 8 C D 3 4 C D 3 4 CD3- CD4+, CD8+ P r e - N K M a t u r e N K + C D 3 Bone Marrow Stroma IL-2, IL-7, stem cell factor (SCF) + C D 1 6 , CD56+ CD3-, CD4-, CD8- Thymus not required for development. Normal NK cells in scid mice and mice without RAG1 or RAG2

  27. NK Cells - Distribution • ~5-20% peripheral blood lymphocytes • ~5% lymphocytes in spleen • Rare in uninfected lymph nodes • >90% of lymphocytes in placenta

  28. NK Cells - Effector Functions • Cell mediated-cytotoxicity • Perforin granzyme pathway • Secreted or membrane TNF-a • Antibody-dependent cellular cytotoxicity (ADCC) • Cytokine secretion • Early g-interferon production • Secretion of TNF-a, LT-a, GM-CSF, IL-5, M-CSF, IL-3, IL-10, IL-13.

  29. Antibody-dependent cellular cytotoxicity (ADCC) Cells that perform ADCC must have FC receptors to bind Ig molecules and trigger killing of target cell.

  30. Cytokine secretion of NK cells Role for IFN-g Viruses Varicella zoster virus & CMV are life-threatening in humans lacking NK cells. Bacteria NK cells protect against intracellular bacteria which tend to infect macrophages. (e.g. Listeria Toxoplasma, Leishmania)

  31. Natural Killer (NK) CellsPart of Early Immune Response

  32. NK are lymphocytes without traditional antigen receptors How do they get activated? • NK cells express both activating and inhibitory receptors • Inhibitory receptors recognize MHC class I (self) on target cells • Activating receptors recognize ligands upregulated on infected cells or tumor cells – +

  33. NK cell Activating ReceptorsHave ITAMs Intracellular signal of lymphocyte receptors through ITAMs. Immunoreceptor Tyrosine based Activating motifs (ITAMs).

  34. Ligand STIMULATORY RECEPTOR (FcR, NKR-P1, NKG2D) - - + DAP12 Protein Tyrosine Kinase Immunoreceptor tyrosine-based Activation motif (ITAM) YxxL x 2 Y Y P X X X X e.g. SYK L L P h o s p h o r y l a t i o n o f s u b s t r a t e s NK cell Activating ReceptorsHave ITAMs

  35. Class I MHC Specific NK Inhibitory Receptors Killer Inhibitory Receptors(KIR) 10-12 genes Extensive allelic polymorphism KIR genes found in primates, but not rodents Ly49 ~10 genes Extensive allelic polymorphism Deleted from the human genome. m o u s e h u m a n C D 9 4 N K G 2 A / C / E L y 4 9 K I R K I R2DL K I R3DL C - t y p e l e c t i n - r e l a t e d f a m i l y I g S F = I m m u n o r e c e p t o r t y r o s i n e - b a s e d i n h i b i t o r y m o t i f ( I T I M )

  36. ITIMs on Lymphocyte Receptors Inhibitory receptors have ITIMs to prevent activation. (Act in opposition to ITAMs)

  37. M H C P ITIM Signaling through Inhibitory Receptors Inhibitory receptor V P R O T E I IN X T Y R O SI I N E Y P H O S P H A T A S E X E.g. Immunoreceptor tyrosine-based Inhibitory motif= ITIM V/IxYxxL/V X L Shp-1 De-phosphorylation of signaling molecules

  38. + NK Cell Target - NK cell activation is regulated by integrated positive and negative signals Activate Inhibit Outcome No No No killing No Yes No killing Yes No Killing Yes Yes No killing/killing NK Cells kill cells expressing activating ligands but need to have inhibitory receptors to protect MHC expressing cells.

  39. Ligands for NK cell activating receptors Very little known about NK activating receptors and their ligands NKG2D (activating receptor) Recognizes “MHC-like” ligands (2m-independent) MIC-A, MIC-B (humans) Rae-1 family (mice) These ligands are induced during viral infection and cellular stress Ligands for many of the activating receptors have not been identified yet…

  40. NK Cell- Opposing Signal Model

  41. Inducible Ligand Model NK cell Normal Cell MHC – No killing + Infected Cell NK cell MHC – Killing + Ligand Ligand induced by stress or infection In these situations, activating receptor can overcome inhibitory signal

  42. Summary NK cells activation is controlled by the balance between activating and inhibitory receptors. Inhibitory receptors bind MHC class I molecules and prevent inappropriate lysis of self cells. NK cells are activated by “missing self”, which can occur when viruses or tumor cells downregulate MHC class I to avoid recognition by CTL. Some ligands for activating receptors are constitutively expressed. Others are induced upon viral infection or stress.

More Related